What Aldo-Union does

Aldo-Unión (legal name: LABORATORIO ALDO-UNIÓN, S.L.) is a privately held, family-owned Spanish pharmaceutical laboratory founded in 1961 by Dr. José Mª Calzada Badía and headquartered in Esplugues de Llobregat, Barcelona. The company develops, manufactures, and commercializes a broad portfolio of branded and generic (EFG) medications across respiratory, dermatological, digestive/metabolic, cardiovascular, neurological, anti-infective, musculoskeletal, and hormonal therapeutic areas, with a particular concentration in inhalation-route products (pressurized metered-dose inhalers, nasal sprays, nebulizer suspensions, and inhalation capsules). It also markets a medical-device range that includes inhalation chambers (Universal Chamber), nebulizer systems (Nebualdo line), and CBD-based topical and nasal products (Onilis).

The company's manufacturing platform is centered on a single GMP-certified plant in Barcelona producing multiple dosage forms (solutions, suspensions, aerosols, nasal sprays, syrups, creams, ointments, emulsions, tablets, capsules, and suppositories) using low-environmental-impact propellants. Aldo-Unión holds pioneering intellectual property positions, including being the first worldwide to commercialize silver sulfadiazine as a medication (Silvederma, 1961) and the first in Spain to launch an inhalation aerosol (Aldo-Asma, 1964). The portfolio is protected by SNS reimbursement inclusion for most products and is priced in the low-to-mid double-digit euro range per pack.

Commercially, Aldo-Unión operates its own medical representative (visitadores médicos) network for domestic promotion and reaches 60+ countries through partner companies and licensing/codevelopment arrangements. Revenue streams comprise proprietary product sales, licensed/codeveloped products (royalty/licensing income), and contract manufacturing services for third parties. The firm employs 51-100 people, is privately held with no disclosed funding rounds or external investors, and pursues modest growth through line extensions (CBD devices, new nebulizer hardware) rather than transformational expansion.

Name

Aldo-Union

Legal name

LABORATORIO ALDO-UNIÓN, S.L.

Website

https://aldo-union.com

Company type

Private

Founded year

1961

Operating status

Operating

Headcount range

51–100 employees

Short description

Aldo-Unión is a privately held Spanish pharmaceutical laboratory (founded 1961) that develops, manufactures, and sells branded and generic respiratory, dermatological, and specialty medications plus medical devices, distributed via its own medical-rep network in Spain and partner companies in 60+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Respiratory & Allergy Pharmaceuticals (HLAIAAAH)

akta.pro secondary industries

Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF), Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories) (HLAHAGAE), Cold, Flu & Cough Remedies (HLAIADAB)

Keywords

• Pharmaceutical manufacturing
• Inhalation medications
• Generic pharmaceuticals
• Contract manufacturing
• Respiratory medicines

Headquarters

HQ city

Esplugas De Llobregat

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Proprietary pharmaceutical products: Aldo-Unión develops, manufactures, and commercializes its own portfolio of pharmaceutical products including medications for respiratory diseases (asthma, COPD), dermatological products, digestive/metabolic treatments, and more. Products are sold through the company's own medical representative network in Spain and internationally via partner companies.
2. Licensed/Codeveloped products: The company commercializes a wide range of drugs under license alongside its proprietary products, expanding its portfolio through partnerships.
3. Contract manufacturing services: The company offers contract manufacturing services as part of its service offerings.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Aldo-Unión develops, manufactures, and commercializes a broad portfolio of proprietary and licensed prescription pharmaceuticals, specializing in respiratory medications (inhalation aerosols, nasal sprays, nebulizer solutions, syrups), dermatological products (silver sulfadiazine), digestive/metabolic treatments, anticoagulants, antithyroid drugs, corticosteroids, NSAIDs, antidepressants and sleep aids. The company also supplies inhalation medical devices (Universal Chamber, Nebualdo nebulizers, Muconeb saline) and offers contract manufacturing services through its GMP-certified plant in Esplugues de Llobregat (Barcelona).

Product overview

Aldo-Unión is a pharmaceutical laboratory founded in 1961 that produces and commercializes a broad portfolio of medications and medical devices. The company operates under the motto 'Comprometidos con la salud' (Committed to health) and maintains its own network of medical sales representatives. Their medication portfolio spans multiple therapeutic groups including: respiratory medications (inhalers like Ventoduo, Ventoaldo, Beclo-asma, Budesonida products, Salbutamol, Formoterol; nasal sprays like Nasoaldo, Rinoduo, Beclo-Rino; nebulizer solutions like Salbuair, Budena, Combiprasal, Bromuro de Ipratropio; and respiratory syrups like Aldobronquial, Histaverin), digestive/metabolism products (Ursobilane for gallstones, Entero Silicona for gas relief, Proctosteroid for rectal conditions), dermatological products (Silvederma antibiotic cream/spray, Aldoderma corticosteroid ointment), cardiovascular medications (Aldocumar anticoagulant), neurological/psychiatric products (Aldosomnil sleeping aid, Deprelio antidepressant), anti-infectives (Tediprima antibiotic), musculoskeletal products (Ibuprofeno, Paidofebril NSAIDs, Paidocort corticosteroid), and hormonal preparations (Tirodril antithyroid, Paidocort). Their medical device portfolio includes Universal Chamber inhalation chambers and masks, Nebualdo nebulizer devices (Easy Pro, Hands Free, Pocket Control), Muconeb sterile hypertonic saline solutions, and Onilis CBD topical products. The company has extensive international presence in over 60 countries and manufactures at its GMP-certified plant in Esplugues de Llobregat, Barcelona.

Differentiator

Problem solved

Functional benefit

Brands

• Nebualdo: Nebulizer product line including Nebualdo Easy Pro, Nebualdo Hands Free, Nebualdo Pocket Control, and Nebualdo Nebulizador.
• Universal Chamber

Products and services

• Ventoduo 100mcg/50mcg inhalation suspension Combined pressurized metered-dose inhaler containing salbutamol (short-acting bronchodilator) and beclometasone dipropionate (corticosteroid) for asthma treatment in patients requiring both agents. Prescription-only medication, included in SNS with reduced patient contribution.
• Ventoaldo 100mcg/dose inhalation suspension Bronchodilator pressurized metered-dose inhaler containing salbutamol for symptomatic treatment of bronchospasm and prevention of exercise- or allergen-induced bronchospasm. Prescription-only.
• Beclo-Asma 50mcg/100mcg inhalation solution Corticosteroid pressurized metered-dose inhaler containing beclometasone dipropionate for prevention of asthma symptoms in patients requiring regular treatment. Prescription-only, included in SNS.
• Beclo-Rino 50mcg nasal spray Nasal spray containing beclometasone dipropionate for temporary relief of allergic rhinitis symptoms caused by pollen, animal dander, dust, or other allergens. Prescription-only, included in SNS.
• Budena 0.25mg/ml / 0.5mg/ml nebulizer suspension Nebulizer suspension containing budesonide for maintenance treatment of asthma and treatment of severe subglottic laryngitis requiring hospitalization. Prescription-only, included in SNS.
• Budesonida Aldo-Unión inhalation and nasal products Corticosteroid range in inhalation suspensions (50/100/200mcg), nebulizer suspensions (0.25/0.5mg/ml), and nasal sprays (64/100mcg) for asthma treatment and allergic rhinitis relief. Prescription-only, included in SNS.
• Combiprasal 0.5mg/2.5mg nebulizer solution Nebulizer solution combining ipratropium bromide and salbutamol for treatment of reversible bronchospasm associated with COPD in patients requiring multiple bronchodilators. Prescription-only, included in SNS.
• Bromuro de Ipratropio Aldo-Unión 250mcg/ml / 500mcg/ml nebulizer solution Nebulizer solution containing ipratropium bromide for treatment of bronchospasm associated with chronic obstructive diseases in adults and children over 12 years. Prescription-only, included in SNS.
• Salbuair 2.5mg / 5mg nebulizer solution Nebulizer solution containing salbutamol sulfate for treatment of chronic bronchospasm unresponsive to conventional therapy and acute severe asthma. Prescription-only, included in SNS.
• Salbutamol Aldo-Unión 100mcg/dose inhalation suspension Bronchodilator pressurized metered-dose inhaler containing salbutamol for symptomatic treatment of bronchospasm in bronchial asthma and prevention of exercise- or allergen-induced bronchospasm. Prescription-only, included in SNS.
• Atroaldo 20mcg/pulse inhalation solution Bronchodilator pressurized metered-dose inhaler containing ipratropium bromide for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary diseases (COPD). Prescription-only, included in SNS.
• Formoterol Aldo-Unión 12mcg inhalation powder capsules Long-acting bronchodilator dry-powder inhalation in hard capsules containing formoterol for treatment and prevention of COPD, asthma, chronic bronchitis, and exercise-induced bronchospasm. Prescription-only, included in SNS.
• Fluticasona Aldo-Unión 0.25mg/ml / 1mg/ml nebulizer suspension Nebulizer suspension containing fluticasone propionate for prevention of severe chronic asthma in adults and adolescents requiring high-dose inhaled or oral corticosteroids. Prescription-only, included in SNS.
• Nasoaldo 50mcg/pulse nasal spray Nasal spray containing mometasone furoate for treatment of hay fever and perennial rhinitis symptoms in adults and children 3 years and older, and nasal polyps in adults 18 years and older. Prescription-only, included in SNS.
• Rinoduo 137mcg/50mcg nasal spray Combination nasal spray containing azelastine hydrochloride (antihistamine) and fluticasone propionate (corticosteroid) for relief of moderate to severe seasonal and perennial allergic rhinitis symptoms. Prescription-only, included in SNS.
• Aldobronquial 2mg/5ml syrup Bronchodilator syrup containing salbutamol for prevention and symptomatic treatment of bronchospasm associated with asthmatic crises and reversible airway obstruction. Prescription-only, included in SNS.
• Histaverin 2mg/ml syrup Antitussive syrup containing codeine for symptomatic treatment of dry or unproductive cough in adults and adolescents over 12 years. Prescription-only, included in SNS.
• Paidoterin descongestivo syrup Decongestant syrup combining phenylephrine, diphenhydramine, and chlorpheniramine for relief of respiratory tract mucosa congestion associated with allergic, perennial, or seasonal rhinitis. Prescription-only.
• Ambroxol Aldo-Unión 15mg/2ml oral solution or nebulizer concentrate Mucolytic agent in oral solution or nebulizer concentrate form for symptomatic treatment of acute and chronic bronchopulmonary processes with excess mucus production and viscosity. Prescription-only.
• Teromol retard 300mg prolonged-release tablets Prolonged-release bronchodilator tablets containing anhydrous theophylline for prevention and treatment of reversible airway closure associated with chronic bronchitis, emphysema, and asthma. Prescription-only, included in SNS.
• Silvederma 10mg/g cream and 10mg/ml cutaneous spray (silver sulfadiazine) Topical antibiotic containing silver sulfadiazine for treatment and prevention of infections in second- and third-degree burns, varicose ulcers, and pressure ulcers. Aldo-Unión was the first company worldwide to commercialize silver sulfadiazine as a medication in cream and aerosol form.
• Aldoderma 1mg/g + 3.5mg/g ointment Topical medication combining triamcinolone acetonide (corticosteroid) and framicetin sulfate (antibiotic) for relief of skin inflammation and itching caused by corticosteroid-responsive disorders secondarily infected by bacteria sensitive to framicetin. Prescription-only.
• Aldocumar 1mg / 3mg / 5mg / 10mg tablets (warfarin) Oral anticoagulant tablets containing warfarin sodium for prophylaxis and/or treatment of venous thromboses, pulmonary embolism, and thromboembolic complications associated with atrial fibrillation and/or heart valve replacement. Prescription-only, included in SNS.
• Tirodril 5mg / 10mg tablets (thiamazole) Antithyroid tablets containing thiamazole (methimazole) for control of thyroid hormone overproduction in hyperthyroidism, thyroid surgery preparation, and radioactive iodine treatment. Prescription-only, included in SNS.
• Ursobilane 150mg / 300mg / 500mg capsules (ursodeoxycholic acid) Bile acid dissolution capsules containing ursodeoxycholic acid for dissolving cholesterol gallstones and treatment of primary biliary cirrhosis. Prescription-only, included in SNS.
• Entero Silicona 9mg/ml oral emulsion (simeticone) Oral emulsion containing simeticone for symptomatic relief of gas in adults, children, and infants by destroying gas bubbles in the intestine. Non-prescription medication.

Quantifiable outcome

• Presence in over 60 countries

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• ALBI España (Asociación para la Lucha contra las Enfermedades Biliares Inflamatorias)minorOthersAldo-Unión collaborates with ALBI España to support patients and their health, contributing to raising awareness and fighting against biliary inflammatory diseases. The partnership focuses on patient support and health advocacy.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Chiesi Farmaceutici: Privately held Italian pharmaceutical company with a strong respiratory franchise (including inhaled therapeutics) and a family-ownership profile. Closely comparable to Aldo-Unión in being a privately controlled, specialty pharma focused on inhalation and respiratory care across multiple global markets.
• Reig Jofre: Spanish specialty pharmaceutical manufacturer with a similar product mix spanning respiratory, dermatology, and hospital injectable categories. Comparable as a mid-sized Spanish pharma producing branded and generic medicines for the SNS system and international markets.
• Faes Farma: Spanish pharmaceutical company with branded prescription, OTC, and consumer health products. Comparable to Aldo-Unión in serving Spanish SNS with branded respiratory and specialty products, plus export-oriented growth.
• Zambon: Italian privately held pharmaceutical company with branded prescription, respiratory, and specialty care products across European and emerging markets. Comparable to Aldo-Unión as a privately controlled, mid-sized European specialty pharma with similar therapeutic mix and international partner-based distribution.

Broad incumbents

• Laboratorios ROVI: Larger Spanish specialty pharmaceutical company with branded prescription and contract manufacturing services. Comparable to Aldo-Unión in offering proprietary Spanish pharma products plus third-party manufacturing, with a broader portfolio and stronger public market positioning.
• Almirall: Spanish dermatology-focused pharmaceutical company operating across Europe with branded prescription products. Comparable to Aldo-Unión as a Spain-headquartered specialty pharma with strong dermatology and respiratory adjacencies, but at materially larger scale.
• Teva Pharmaceutical Industries: Global generic pharmaceutical leader with a substantial respiratory portfolio (including ProAir and branded respiratory devices). Comparable as a broad respiratory and EFG competitor to Aldo-Unión, though operating at vastly greater scale with global distribution.

Emerging players

• Cipla: Indian generic pharmaceutical company with a leading global respiratory franchise (inhalers, nebulizers, nasal sprays). Comparable to Aldo-Unión in its focus on affordable respiratory therapies and contract manufacturing, though operating at much greater scale and emerging-market reach.
• Glenmark Pharmaceuticals: India-headquartered specialty pharma with a respiratory franchise spanning inhalers, nasal sprays, and nebulizer products for global markets. Comparable to Aldo-Unión in its focus on inhalation products and emerging-market distribution, with overlapping EFG strategy.

Regional players

• Orion Corporation: Finnish pharmaceutical company with a strong respiratory and specialty generics franchise (Easyhaler inhaler platform). Comparable to Aldo-Unión in respiratory inhaler manufacturing and EFG offerings, with overlapping primary-care distribution across Europe.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@laboratorioaldo-unions.l693
• LinkedInlinkedin.com/company/aldo-uni-n
• Facebookfacebook.com/cntaldounion

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aldo-Union